CXCL8 and neoplasm: The IL8-CXCR1/2 axis can modulate the phenotypic status of tumor cells by activating a cellular differentiation program known as epithelial–mesenchymal transition (EMT), which endows tumor cells with enhanced metastatic, stemness, and resistance qualities [26].